Brown Advisory’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-4,395
| Closed | -$203K | – | 1243 |
|
|
2021
Q3 | $203K | Sell |
4,395
-1,025
| -19% | -$47.3K | ﹤0.01% | 1037 |
|
|
2021
Q2 | $298K | Hold |
5,420
| – | – | ﹤0.01% | 941 |
|
|
2021
Q1 | $280K | Hold |
5,420
| – | – | ﹤0.01% | 961 |
|
|
2020
Q4 | $234K | Buy |
+5,420
| New | +$234K | ﹤0.01% | 933 |
|
|
2020
Q3 | – | Sell |
-5,439
| Closed | -$291K | – | 962 |
|
|
2020
Q2 | $291K | Sell |
5,439
-340
| -6% | -$18.2K | ﹤0.01% | 821 |
|
|
2020
Q1 | $205K | Sell |
5,779
-1,125
| -16% | -$39.9K | ﹤0.01% | 860 |
|
|
2019
Q4 | $330K | Sell |
6,904
-359,330
| -98% | -$17.2M | ﹤0.01% | 856 |
|
|
2019
Q3 | $11.9M | Buy |
366,234
+7,007
| +2% | +$227K | 0.03% | 298 |
|
|
2019
Q2 | $17.9M | Sell |
359,227
-14,782
| -4% | -$737K | 0.05% | 255 |
|
|
2019
Q1 | $25.2M | Buy |
374,009
+26,496
| +8% | +$1.79M | 0.07% | 217 |
|
|
2018
Q4 | $16M | Buy |
347,513
+3,736
| +1% | +$172K | 0.05% | 264 |
|
|
2018
Q3 | $26.5M | Buy |
343,777
+32,799
| +11% | +$2.53M | 0.08% | 217 |
|
|
2018
Q2 | $26.2M | Buy |
310,978
+4,813
| +2% | +$405K | 0.08% | 212 |
|
|
2018
Q1 | $25M | Buy |
306,165
+1,640
| +0.5% | +$134K | 0.08% | 207 |
|
|
2017
Q4 | $17.4M | Buy |
304,525
+13,386
| +5% | +$765K | 0.06% | 246 |
|
|
2017
Q3 | $19.4M | Buy |
291,139
+22,736
| +8% | +$1.52M | 0.06% | 232 |
|
|
2017
Q2 | $13.8M | Buy |
268,403
+4,861
| +2% | +$250K | 0.04% | 268 |
|
|
2017
Q1 | $15.4M | Buy |
263,542
+142,181
| +117% | +$8.3M | 0.05% | 246 |
|
|
2016
Q4 | $5.06M | Buy |
+121,361
| New | +$5.06M | 0.02% | 373 |
|